Loading data for SION — first visit, this takes a few seconds.
Sionna Therapeutics, Inc. (SION)
NasdaqGM: SION
· 即時價格 · USD
6.75
-0.56 (-7.66%)
收盤價： Sep 04, 2026, 8:00 PM
股價、關鍵數字和最新消息，都在這一頁。
Sionna Therapeutics, Inc.（SION）股價、分析與資料
無可用資料
| 買價 | 35.98 |
| 市值 | 324M |
| 營收 (ttm) | n/a |
| 淨利（ttm） | -97.4M |
| 0.00 | |
| -2.15 | |
| n/a | |
| -2.84 | |
| P/B (ttm) | 1.22 |
| P/S (ttm) | 0.00 |
| 財報日期 | Nov 5, 2026 |
| 賣價 | 64.74 |
| 成交量 | 1,242,035 |
| 20 日平均成交量 | 1,852,079 |
| 開盤價 | 7.31 |
| 前收盤價 | 7.31 |
| 當日區間 | 6.70 - 7.56 |
| 52 週範圍 | 4.01 - 54.97 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 SION
Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a transmembrane domain 1 (TMD1)-directed cystic fibrosis transmembrane conductance regulator (CFTR) that has completed Phase 2 trial; navocaftor (SION-3067), a potentiator that has completed Phase 2 trial; SION-109, an intracellular loop 4 directed CFTR corrector th...
完整的公司簡介財報驚奇
Sionna Therapeutics 已於 Aug 6, 2026 公布季度財報：
- 營收為 $0 低於預期 $0, 年增 NaN% 成長.
- 每股盈餘為 -0.66 低於預期 -0.01, 年增 -60.98% 下滑.
第 1 頁，共 2 頁